Wyoming 2023 Regular Session

Wyoming Senate Bill SF0007

Introduced
1/10/23  
Report Pass
1/13/23  
Engrossed
1/17/23  
Refer
2/7/23  
Report Pass
2/8/23  
Enrolled
2/16/23  

Caption

Definition of opiate antagonist-amendment.

Impact

The legislative change will streamline the conditions under which naloxone can be administered by laypersons and first responders, ultimately fostering a more effective response to drug overdoses. By ensuring comprehensive legal support for the administration of naloxone, the bill has the potential to increase the availability and use of this critical medication in emergency situations, thereby saving lives and improving public health outcomes in Wyoming. This adjustment is crucial in the context of rising overdose statistics, particularly related to opioids.

Summary

Senate File 0007 (SF0007) addresses the definition of opiate antagonists within Wyoming's Emergency Administration of Opiate Antagonist Act. The bill specifically amends the existing legal definition to include naloxone hydrochloride, known by its brand name Narcan, as an approved substance for the treatment of opiate-related overdoses. The legislation aims to clarify the language surrounding the administration of these life-saving drugs, thereby reinforcing the state's commitment to combating the ongoing opiate crisis.

Sentiment

The sentiment surrounding SF0007 appears to be overwhelmingly positive, with substantial support from both legislators and public health advocates who recognize the urgency of addressing opioid overdoses in the state. The bill passed with a significant majority in the legislature, indicating a broad consensus on the necessity of improving access to naloxone for emergency use. This sentiment reflects a proactive approach to public health and safety, underscoring the importance of timely interventions.

Contention

While there were few points of contention raised during the discussions, concerns about the broader implications of increased access to naloxone, particularly regarding its potential misuse or the perception it creates about drug use, were noted by some stakeholders. Nevertheless, the overarching support for the bill suggests that the benefits of enabling faster and easier access to life-saving treatments outweighed these concerns, paving the way for its approval.

Companion Bills

No companion bills found.

Similar Bills

No similar bills found.